EPILEPSI, cilt.23, sa.1, ss.13-18, 2017 (ESCI, Scopus, TRDizin)
Objectives: Levetiracetam (LEV) is an antiepileptic drug approved particularly for treatment of focal seizures. The aim of this study was to investigate efficacy and tolerability of LEV monotherapy in pediatric patients.